When was LTR Pharma founded?

LTR Pharma was founded in 2020.

Where is LTR Pharma located?

LTR Pharma is headquartered in Brisbane, Australia.

How many employees does LTR Pharma have?

As of Apr 30, 2026, the latest employee count at LTR Pharma is 13.

Is LTR Pharma a funded company?

LTR Pharma is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does LTR Pharma rank among its competitors?

LTR Pharma ranks 5th amongst 21 active competitors, of which 7 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Lipella, which secured $1.35M in Aug, 2025.

Who are the top competitors of LTR Pharma?

LTR Pharma's top competitors include Lipella, Kissei Pharmaceutical and Antev. Among them, Lipella secured the most recent funding round in August, 2025.

LTR Pharma - 2026 Company Profile & Competitors

LTR Pharma is a public company based in Brisbane (Australia), founded in 2020. It operates as a Developer of therapeutics for the treatment of erectile dysfunction. The company has 21 active competitors, including 7 funded and 7 that have exited. Its top competitors include companies like Lipella, Kissei Pharmaceutical and Antev.

Company Details

Developer of therapeutics for the treatment of erectile dysfunction. The drug candidate SDS-089 is Vardenafil which is a PDE5 inhibitor and intranasal drug delivery platform for the treatment of erectile dysfunction.

Website: ltrpharma.com
Phone Number: +61 **********

Key Metrics

Founded Year

2020

Location

Brisbane, Australia

Stage

Public

Ranked

5^th among 21 active competitors

Employee Count

13 as on Apr 30, 2026

Similar Companies

Lipella & 27 more

Exit Details

Public

View LTR Pharma's full profile

LTR Pharma got listed on Dec 11, 2023.

Click here to take a look at LTR Pharma's IPO in detail

LTR Pharma has not raised any funding rounds yet.

LTR Pharma's employee count trend

LTR Pharma has 13 employees as of Apr 26. Here is LTR Pharma's employee count trend over the years:

Uncover LTR Pharma's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of LTR Pharma include Lipella, Kissei Pharmaceutical and Antev. Here is the list of Top 10 competitors of LTR Pharma, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Lipella 2005, Pittsburgh (United States), Public	Developer of lipid-based therapies for common bladder syndromes	$3.37M	Military Health, HHS	58/100
2nd	Kissei Pharmaceutical 1946, Matsumoto (Japan), Public	Developer of therapies for treating renal diseases and urology related anaemia	-	-	56/100
3rd	Antev 2013, London (United Kingdom), Acquired	GnRH antagonists for urology indications in humans & animals	-	-	50/100
4th	NEXT Life Sciences 2021, San Luis Obispo (United States), Seed	Developer of male contraception procedures	$4.05M	Transform VC, The Family & 8 others	50/100
5th	LTR Pharma 2020, Brisbane (Australia), Public	Developer of therapeutics for the treatment of erectile dysfunction	-	-	45/100
6th	Regrow 2009, Mumbai (India), Seed	Provider of autologous cell therapy for tissue repair and stem cell banking services	$2.84M	Ascus International, Satyan Pharmaceuticals ... & 7 others	44/100
7th	Esprit Pharma 2005, East Brunswick (United States), Acquired	Develop drugs for genitourinary (GU) disorders	$219M	Apax, Domain Associates & 5 others	44/100
8th	Urigen Pharmaceuticals 1997, North Brunswick (United States), Series A	Developer of pain relief products for patients with urological ailments	$6.05M	-	40/100
9th	Sumitomo 2017, Irvine (United States), Public	Developer of therapies for treating urological disorders	-	Hercules Capital, Sumitovant	38/100
10th	Acerus Pharma 2008, Mississauga (Canada), Deadpooled	Developing drugs for treating urology, hormone replacement therapy & female sexual dysfunction	$27.6M	SWK Holdings, MidCap Financial & 2 others	37/100